TAVI vs SAVR Age Threshold — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — SAVR is recommended for patients <70 years at low surgical risk — the 2025 guidelines set the age threshold for TAVI recommendation at ≥70 years; below 70, SAVR remains the standard of care due to longer-term durability data
The 2025 ESC/EACTS VHD Guidelines updated the age-based recommendations for AVR in severe AS: (1) Age ≥70 years: TAVI recommended (Class I) for patients with tricuspid AV and suitable anatomy, irrespective of surgical risk — based on DEDICATE-DZHK6, NOTION-2, and low-risk trial data; (2) Age <70 years: SAVR recommended (Class I) at low surgical risk — because: (a) TAVI valve durability data beyond 10 years are limited; (b) younger patients will likely outlive a TAVI valve and need reintervention; (c) SAVR has established 15-20 year outcomes; (d) redo SAVR after TAVI is technically challenging. For patients aged 60-70 with intermediate risk, the Heart Team decision considers lifetime valve management, coronary anatomy, vascular access, and patient preference.
Reference: ESC/EACTS (2025): VHD Guidelines